Among patients with HER2-low tumors, those with high-grade TNBC ST displayed a lower Ki-67 index (p < 0.001) and a significantly lower (pre-treatment) histological tumor grade (p = 0.015) compared to their HER2-low TNBC NST counterparts (Table 2). The gene discussed is ERBB2; the disease is neoplasm.